Key facts
- This page summarizes Roger N. Farah's Form 4 filing for CVS HEALTH Corp (CVS).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 03 Dec 2024, 17:18.
Roger N. Farah - 30 Nov 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)
- Reporting relationship
- Director
- Issuer ticker
- CVS
- Reported as of
- 30 Nov 2024
- Net transaction value
- +$2,999,981
- SEC form
- 4
- Accepted by SEC
- 03 Dec 2024, 17:18:59 UTC
- Prior SEC filing
- 15 Oct 2024
- Next SEC filing
- 21 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Roger N. Farah
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Roger N. Farah filed Form 4 for CVS HEALTH Corp (CVS) on 03 Dec 2024.
Change
- Previous filing in this sequence was filed on 15 Oct 2024.
- Current net transaction value: +$2,999,981.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CVS
transaction
Common Stock (Restricted)
Award
- Transaction value
- $2,999,981
- Shares
- +50,125
- Change %
- Price
- $59.85
- Shares after
- 50,125
- Date
- 30 Nov 2024
- Ownership
- Direct
- Footnotes
- F1
CVS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,124
- Date
- 30 Nov 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CVS
holding
Derivative
Share Credits
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 36,384
- Date
- 30 Nov 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 36,384
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in two equal installments, commencing 11/30/2025.
Footnote F2
Consists of deferred stock units, each to be converted into one share of common stock and issued pursuant to the Reporting Person's election.